Showing 1201-1210 of 1635 results for "".
- Oyster Point Announces Results of Phase 3 Trial of OC-01 Nasal Spray for Treatment of Signs and Symptoms of Dry Eye Diseasehttps://modernod.com/news/oyster-point-announces-results-of-phase-3-trial-of-oc-01-nasal-spray-for-treatment-of-signs-and-symptoms-of-dry-eye-disease/2477743/Oyster Point Pharma announced positive topline results from the phase 3 ONSET-2 study in dry eye disease. The ONSET-2 trial met the primary endpoint, where a greater percentage of subjects treate
- Responding to COVID-19, National Vision and Warby Parker Extend Store Closures, National Vision Moves to Trim Expenseshttps://modernod.com/news/responding-to-covid-19-national-vision-and-warby-parker-extend-store-closures-national-vision-moves-to-trim-expenses/2477481/Two leading optical retailers announced late last week that they are extending the time period in which their stores will be closed due to the coronavirus outbreak, according to a VisionMonday
- ASRS Releases Guidelines to Help Retina Practices Navigate COVID-19 Pandemichttps://modernod.com/news/asrs-releases-guidelines-to-help-retina-practices-navigate-covid-19-pandemic/2477427/The American Society of Retina Specialists (ASRS) has released detailed guidelines to help retina practices reduce risk and help assure the health and safety of patients and medical personnel during the COVID-19 pandemic. The guidelines define what constitutes an essential visit and provide a mea
- Calvin Roberts, MD, Named President and CEO of Lighthouse Guildhttps://modernod.com/news/calvin-roberts-md-named-president-and-ceo-of-lighthouse-guild/2477286/Calvin Roberts, MD, has been elected President and CEO of Lighthouse Guild. Dr. Roberts will leave his position as Senior Vice President and Chief Medical Officer, Eye Care, at Bausch Health Companies, on March 31. Dr. Roberts i
- Alexander van der Mey Named New CCO at Optimo Medical AGhttps://modernod.com/news/alexander-van-der-mey-named-new-cco-at-optimo-medical-ag/2477248/As of January 16, Alexander van der Mey assumed the role of chief commercial officer (CCO) position of Optimo Medical AG. In his new position, Mr. van der Mey is responsible for global marketing and sales. Mr. Van der Mey has studied business administration in Germany and the Netherlands.
- Oyster Point Pharma’s OC-01 Nasal Spray Meets Primary Endpoint in Phase 2 Mystic Trial in Subjects With Dry Eye Diseasehttps://modernod.com/news/oyster-point-pharmas-oc-01-nasal-spray-meets-primary-endpoint-in-phase-2-mystic-trial-in-subjects-with-dry-eye-disease/2477225/Oyster Point Pharma announced positive topline results from its phase 2 MYSTIC study in dry eye disease. Results showed a statistically significant improvement in Schirmer’s score from baseline at Day 84 in both doses as compared to control.
- GenSight Biologics Reports Findings From Studies Highlighting Benefits From Lumevoq Compared to LHON Natural Historyhttps://modernod.com/news/gensight-biologics-reports-findings-from-studies-highlighting-benefits-from-lumevoq-compared-to-lhon-natural-history/2477163/GenSight Biologics reported results from the REALITY registry study and an analysis of REVERSE and RESCUE phase 3 data, which further highlight the poor prognosis for patients with loss of vision due to Leber Hereditary Optic Neuropathy (LHON) associated with the ND4 mutation. The results
- Pharmaceutical Companies Face Steeper Price Cuts in China as Country Expands Drug Bulk-Buying Scheme Nationwidehttps://modernod.com/news/pharmaceutical-companies-face-steeper-price-cuts-in-china-as-country-expands-drug-bulk-buying-scheme-nationwide/2476915/China has expanded across the country a drug procurement program aimed at reducing the cost of generic medicines, a move that may force global pharmaceutical firms to slash their prices by half in order to maintain sales to the country’s public hospitals, Bloomberg
- Carl Zeiss AG Names New President and CEOhttps://modernod.com/news/carl-zeiss-ag-names-new-president-and-ceo/2476913/At its meeting on September 24, the Supervisory Board of Carl Zeiss AG unanimously voted in favor of the following changes to the Executive Board: Dr. Karl Lamprecht, currently a member of the Executive Board, will become the new President & CEO effective April 1, 2020. Dr. Karl Lamprecht wil
- Zeiss and IDOC Partner to Bring Medical and Vision Care Products to Independent Optometrists Nationwidehttps://modernod.com/news/zeiss-and-idoc-partner-to-bring-medical-and-vision-care-products-to-independent-optometrists-nationwide/2476890/IDOC, Zeiss Vision Care US and Zeiss Medical Technology announced a 5-year agreement to bring Zeiss’ lab services, lens products and medical equipment to all 3,000+ IDOC independent optometrists across the United Stat